|
PBRM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.399590E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.002330E-04 |
| Normal-vs-Stage2 |
4.689800E-02 |
| Normal-vs-Stage3 |
9.248400E-04 |
| Normal-vs-Stage4 |
4.9128999979331E-08 |
| Stage1-vs-Stage2 |
7.853200E-01 |
| Stage1-vs-Stage3 |
5.138600E-01 |
| Stage1-vs-Stage4 |
7.175300E-04 |
| Stage2-vs-Stage3 |
4.565000E-01 |
| Stage2-vs-Stage4 |
5.236100E-03 |
| Stage3-vs-Stage4 |
4.485800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.244940E-04 |
| Normal-vs-AfricanAmerican |
2.427700E-04 |
| Normal-vs-Asian |
3.135800E-03 |
| Caucasian-vs-AfricanAmerican |
5.492200E-01 |
| Caucasian-vs-Asian |
5.447000E-01 |
| AfricanAmerican-vs-Asian |
6.540400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.78809999993457E-07 |
| Normal-vs-Female |
7.061600E-01 |
| Male-vs-Female |
1.356640E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.119800E-03 |
| Normal-vs-Extreme_Weight |
9.68299999959399E-07 |
| Normal-vs-Obese |
3.863000E-03 |
| Normal-vs-Extreme_Obese |
1.112270E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.115400E-01 |
| Normal_Weight-vs-Obese |
3.975400E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.997200E-01 |
| Extreme_Weight-vs-Obese |
7.639500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.985800E-01 |
| Obese-vs-Extreme_Obese |
6.007600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.304800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.364300E-03 |
| Normal-vs-Age(61-80Yrs) |
3.47069999995231E-06 |
| Normal-vs-Age(81-100Yrs) |
1.64816000000068E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.336600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.429020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.551500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.082400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.286200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.955640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.49459999999547E-05 |
| Normal-VS-Type2 PRCC |
3.77410000029776E-07 |
| Normal-VS-KIRP CIMP |
6.504200E-02 |
| Normal-VS-Unclassified PRCC |
5.365200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.009600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.062000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.548400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.594400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.637630E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.369000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.58039999998661E-07 |
| Normal-vs-N1 |
1.040930E-03 |
| Normal-vs-N2 |
2.007200E-04 |
| N0-vs-N1 |
6.177200E-01 |
| N0-vs-N2 |
3.243000E-01 |
| N1-vs-N2 |
2.723400E-01 |
|
|
